22351-1-AP

antibody from Proteintech Group

Targeting: CCR3 CC-CKR-3, CD193, CKR3, CMKBR3

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

22351-1-AP

Provider

Proteintech Group

Product name

CCR3 antibody

Antibody type

Polyclonal

Description

CCR3 antibody (Cat. #22351-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC,ELISA.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

CD34(+) PI16(+) fibroblast progenitors aggravate neointimal lesions of allograft arteries via CCL11/CCR3-PI3K/AKT pathway.

Xu X, Zhu P, Wang H, Chen K, Liu L, Du L, Jiang L, Hu Y, Zhou X, Zhang B, Pu X, Hu X, Xu Q, Zhang L, Li W
Theranostics 2025;15(6):2523-2543

---

Immuno-transcriptomic analysis based on machine learning identifies immunity signature genes of chronic rhinosinusitis with nasal polyps.

Xu Z, Hao Q, Yan B, Li Q, Kan X, Wu Q, Yi H, Shen X, Qu L, Wang P, Sun Y
Scientific reports 2025 Jun 3;15(1):19393

---

Emu oil alleviates atopic dermatitis-like responses by inhibiting Cdc42 signaling of keratinocyte.

Bu L, Wang M, Liu X, Zhang M, Zhang Y, Zhang X, Liang F, Huang B, Huang J, Wu S, Tang X, Wang X, Zhang L
International immunopharmacology 2024 Sep 30;139:112706

---

SYNPO2 promotes the development of BLCA by upregulating the infiltration of resting mast cells and increasing the resistance to immunotherapy.

Ye G, Tu L, Li Z, Li X, Zheng X, Song Y
Oncology reports 2024 Jan;51(1)

---

GFPT1 accelerates immune escape in breast cancer by modifying PD-L1 via O-glycosylation.

Tang W, Gao Y, Hong S, Wang S
BMC cancer 2024 Aug 29;24(1):1071